Cadrenal Therapeutics, Inc. SEC filings CVKD
Cadrenal Therapeutics, Inc. has 277 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 8, 2026 | — |
| S-8 | Employee stock plan registration | Sep 3, 2026 | — |
| 424B3 | Prospectus | Jul 20, 2026 | — |
| S-3 | Shelf registration | Jul 13, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| S-3 | Shelf registration | Apr 21, 2026 | — |
| 424B5 | Prospectus supplement | Apr 1, 2026 | — |
| 424B3 | Prospectus | Jan 2, 2026 | — |
| S-1 | Registration statement | Dec 29, 2025 | — |
| 424B5 | Prospectus supplement | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Dec 16, 2025 | — |
| 424B5 | Prospectus supplement | Dec 16, 2025 | — |
| 424B5 | Prospectus supplement | Nov 18, 2025 | — |
| 424B5 | Prospectus supplement | Apr 17, 2025 | — |
| S-8 | Employee stock plan registration | Feb 3, 2025 | — |
| S-8 | Employee stock plan registration | Dec 23, 2024 | — |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| 424B3 | Prospectus | Nov 25, 2024 | — |
| S-3 | Shelf registration | Nov 14, 2024 | — |
| 424B5 | Prospectus supplement | Nov 4, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Apr 2, 2024 | — |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| S-3 | Shelf registration | Mar 12, 2024 | — |
| 424B3 | Prospectus | Aug 16, 2023 | — |
| 424B3 | Prospectus | Aug 1, 2023 | — |
| S-1 | Registration statement | Jul 24, 2023 | — |
| S-8 | Employee stock plan registration | Jan 24, 2023 | — |
| 424B4 | Prospectus | Jan 23, 2023 | — |
| 424B4 | Prospectus | Jan 23, 2023 | — |
| S-1/A | Amended registration statement | Jan 17, 2023 | — |
| S-1/A | Amended registration statement | Dec 28, 2022 | — |
| S-1/A | Amended registration statement | Dec 8, 2022 | — |
| S-1/A | Amended registration statement | Dec 6, 2022 | — |
| S-1/A | Amended registration statement | Oct 17, 2022 | — |
| S-1/A | Amended registration statement | Oct 11, 2022 | — |
| S-1 | Registration statement | Sep 22, 2022 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CVKD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1937993
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.